ACTRIS Cell Therapy Lecture Series: Glycosaminoglycan Bioadditives for the Expansion of Potent Mesenchymal Stem Cells

27 May 2021

Event Name: 

ACTRIS Cell Therapy Lecture Series: Glycosaminoglycan Bioadditives for the Expansion of Potent Mesenchymal Stem Cells

Date: 

27 May 2021

Time: 

12 noon to 1pm

Synopsis: 

Cell therapy is at the forefront of advances in the treatment of disease or injury. Central to the success of cell therapy products is the ability to manufacture them at large scale without a loss in potency.

The mesenchymal stem cell (MSC) offers significant potential for tissue regeneration. However, the low abundance of MSCs in tissues necessitates expansion in culture before clinical application. The Allogeneic Stem Cell Manufacturing (ASTEM) Programme seeks to address bottlenecks to scale-up manufacturing of these cells.

This webinar will introduce the work of ASTEM with a focus on the use of cell culture bioadditives that sustain the growth of multipotent MSC over extended passaging. Example of how improved media formulations for the growth of MSCs translates to enhanced efficacy for MSC therapy will also be highlighted.

Speaker

Prof Simon Cool

Research Director and Professor (Adjunct Research)

Glycotherapeutics Group

Institute of Molecular and Cell Biology

Register: 

Click here

 

GO BACK
Top